Lisa A. Raedler, PhD, RPh | Authors


US-Cuban Partnership Developing Anticancer Vaccine for NSCLC

May 13, 2015

Leaders of Roswell Park Cancer Institute (RPCI) in Buffalo, New York, have agreed to collaborate with the Center for Molecular Immunology (CIM) in Cuba to evaluate a therapeutic anticancer vaccine for non–small cell lung cancer (NSCLC) in the United States.